• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nasdaq Sees Worst Session Since 2022 As Chip Stocks Tumble After Trump's Taiwan Remarks and Biden's Potential Restrictions

    7/18/24 3:27:49 AM ET
    $ABT
    $DHI
    $FIVE
    $NFLX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Homebuilding
    Consumer Discretionary
    Get the next $ABT alert in real time by email

    The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index moving to the “Neutral” zone on Wednesday.

    U.S. stocks closed mixed on Wednesday, with the Nasdaq Composite recording its worst session since Dec. 2022.

    On the economic data front, industrial production in the U.S. climbed 0.6% from a month ago in June compared to market estimates of a 0.3% gain. U.S. housing starts increased by 3% from the prior month to an annualized rate of 1,314,000 in June, while building permits climbed by 3.4% to an annual rate of 1.446 million in June.

    Semiconductor stocks moved lower on Wednesday amid reports Biden is considering further China restrictions and Trump asking Taiwan to pay the U.S. for defense. Following the ex-president’s comments Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) ended the day nearly 8% lower.

    Synchrony Financial (NYSE:SYF) reported better-than-expected second-quarter results on Wednesday. Five Below, Inc. (NASDAQ:FIVE) shares dipped 25% on Wednesday after the company announced a CEO transition and said comparable sales decreased in the 10-week period ended July 13.

    Most sectors on the S&P 500 closed on a positive note, with energy, consumer staples and financials stocks recording the biggest gains on Wednesday. However, communication services and information technology stocks bucked the overall market trend, closing the session lower.

    The Dow Jones closed higher by around 244 points to 41,198.08 on Wednesday. The S&P 500 fell 1.39% at 5,588.27, while the Nasdaq Composite dipped 2.77% at 17,996.92 during Wednesday's session.

    Investors are awaiting earnings results from D.R. Horton, Inc. (NYSE:DHI), Abbott Laboratories (NYSE:ABT) and Netflix, Inc. (NASDAQ:NFLX) today.

    What is CNN Business Fear & Greed Index?

    At a current reading of 53.9, the index moved to the “Neutral” zone on Wednesday, versus a prior reading of 61.

    The Fear & Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.

    Read Next:

    • Top 3 Industrials Stocks That Could Sink Your Portfolio This Month

    Image Via Shutterstock

    Get the next $ABT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABT
    $DHI
    $FIVE
    $NFLX

    CompanyDatePrice TargetRatingAnalyst
    Netflix Inc.
    $NFLX
    3/30/2026Mkt Perform
    Citizens
    Netflix Inc.
    $NFLX
    3/24/2026Hold → Buy
    Erste Group
    Five Below Inc.
    $FIVE
    3/19/2026Mkt Perform → Outperform
    William Blair
    Five Below Inc.
    $FIVE
    3/19/2026$240.00 → $260.00Outperform
    Telsey Advisory Group
    Netflix Inc.
    $NFLX
    3/18/2026$115.00Buy
    Citigroup
    Netflix Inc.
    $NFLX
    3/9/2026$105.00Equal Weight
    Wells Fargo
    D.R. Horton Inc.
    $DHI
    3/4/2026$155.00Hold
    Truist
    Netflix Inc.
    $NFLX
    3/2/2026$115.00Equal Weight
    Barclays
    More analyst ratings

    $ABT
    $DHI
    $FIVE
    $NFLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citizens initiated coverage on Netflix

    Citizens initiated coverage of Netflix with a rating of Mkt Perform

    3/30/26 8:19:42 AM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Netflix upgraded by Erste Group

    Erste Group upgraded Netflix from Hold to Buy

    3/24/26 12:31:36 PM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Five Below upgraded by William Blair

    William Blair upgraded Five Below from Mkt Perform to Outperform

    3/19/26 8:22:53 AM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    $ABT
    $DHI
    $FIVE
    $NFLX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Starks Daniel J bought $1,087,331 worth of Common shares without par value (10,000 units at $108.73), increasing direct ownership by 0.15% to 6,738,817 units (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    2/6/26 8:04:16 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CHAIRMAN AND CEO Ford Robert B bought $2,013,967 worth of Common shares without par value (18,800 units at $107.13) (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    1/26/26 8:02:24 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $DHI
    $FIVE
    $NFLX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 24, 2023 - FDA Approves New Therapy for Rare Form of Blood Cancers Called Myelodysplastic Syndromes

    For Immediate Release: October 24, 2023 Today, the U.S. Food and Drug Administration approved Tibsovo (ivosidenib) for the treatment of adult patients with relapsed or refractory (R/R) myelodysplastic syndromes (MDS) with an isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test. This is the first targeted therapy approved for this indication. The agency also approved the Abbott RealTime

    10/24/23 3:52:17 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $DHI
    $FIVE
    $NFLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Neumann Spencer Adam

    4 - NETFLIX INC (0001065280) (Issuer)

    4/3/26 4:07:32 PM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    SEC Form 4 filed by Kilgore Leslie J

    4 - NETFLIX INC (0001065280) (Issuer)

    4/2/26 6:02:54 PM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    SEC Form 4 filed by Masiyiwa Strive

    4 - NETFLIX INC (0001065280) (Issuer)

    4/2/26 6:02:46 PM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $ABT
    $DHI
    $FIVE
    $NFLX
    SEC Filings

    View All

    SEC Form 144 filed by Netflix Inc.

    144 - NETFLIX INC (0001065280) (Subject)

    4/1/26 4:10:08 PM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    D.R. Horton Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - HORTON D R INC /DE/ (0000882184) (Filer)

    3/31/26 5:15:01 PM ET
    $DHI
    Homebuilding
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by Synchrony Financial

    SCHEDULE 13G/A - Synchrony Financial (0001601712) (Subject)

    3/27/26 1:18:45 PM ET
    $SYF
    Finance: Consumer Services
    Finance

    $ABT
    $DHI
    $FIVE
    $NFLX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Synchrony Named No. 1 Best Company to Work For in the U.S., Powered by a High-Trust Culture that Fuels Innovation

    Top employer recognition by Fortune and Great Place To Work® spotlights Synchrony's employee-first workplace built on trust, accelerating innovation and business performance Key Highlights Synchrony ranked No. 1 on the Fortune 100 Best Companies to Work For® list, catapulting from No. 37 in 2021Nearly 100% of senior leaders use AI tools and nearly 80% of employees say AI will positively impact their careersHigh-trust culture, skills-first development and flexible hybrid model fuel growth, innovation and better business outcomesSTAMFORD, Conn., April 1, 2026 /PRNewswire/ -- Synchrony (NYSE:SYF), a leading consumer financing company, today announced it has been named the No. 1 Best Company to

    4/1/26 8:23:00 AM ET
    $SYF
    Finance: Consumer Services
    Finance

    Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform

    Broadens access to Abbott's Precision Oncology tests across more than 1,600 community cancer care centers and 4,700 providers in Flatiron's North America network, helping accelerate informed treatment decisionsAllows oncologists to order tests and view results directly in the clinical workflowABBOTT PARK, Ill. and NEW YORK, March 30, 2026 /PRNewswire/ -- Abbott (NYSE:ABT), the global healthcare company, and Flatiron Health, a leading healthtech company advancing point-of-care solutions in oncology, today announced the integration of Abbott's comprehensive Precision Oncology portfolio into OncoEMR®, Flatiron's cloud-based Electronic Medical Record (EMR) platform. Through this integration, onc

    3/30/26 9:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Abbott hosts conference call for first-quarter earnings

    ABBOTT PARK, Ill., March 26, 2026 /PRNewswire/ -- Abbott (NYSE:ABT) will announce its first-quarter 2026 financial results on Thursday, April 16, before the market opens. The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern) and will be accessible through Abbott's Investor Relations website at www.abbottinvestor.com. An archived edition of the call will be available later that day.About Abbott: Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical

    3/26/26 9:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $DHI
    $FIVE
    $NFLX
    Financials

    Live finance-specific insights

    View All

    Abbott hosts conference call for first-quarter earnings

    ABBOTT PARK, Ill., March 26, 2026 /PRNewswire/ -- Abbott (NYSE:ABT) will announce its first-quarter 2026 financial results on Thursday, April 16, before the market opens. The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern) and will be accessible through Abbott's Investor Relations website at www.abbottinvestor.com. An archived edition of the call will be available later that day.About Abbott: Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical

    3/26/26 9:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Synchrony to Announce First Quarter 2026 Financial Results on April 21, 2026

    STAMFORD, Conn., March 24, 2026 /PRNewswire/ -- Synchrony (NYSE: SYF) plans to report its first quarter 2026 results on Tuesday, April 21, 2026. The earnings release and presentation materials are scheduled to be released and posted to the Investor Relations section of the Company's website, www.investors.synchrony.com, at approximately 6:00 a.m. Eastern Time.  A conference call to discuss Synchrony's results will be held at 8:00 a.m. Eastern Time on that day; the live audio webcast and replay can be accessed through the same website under Events and Presentations. About Synchro

    3/24/26 8:00:00 AM ET
    $SYF
    Finance: Consumer Services
    Finance

    Abbott completes acquisition of Exact Sciences

    Establishes Abbott as a leader in fast-growing cancer screening and diagnostics segmentsAdvances Abbott's mission to make healthcare more accessible and give people more control over their healthABBOTT PARK, Ill., March 23, 2026 /PRNewswire/ -- Abbott (NYSE:ABT) today announced it has completed the acquisition of Exact Sciences, establishing Abbott as a leader in fast-growing cancer screening and diagnostics segments and enabling the company to serve millions of additional people. "Abbott's global scale, track record of operational and commercial excellence and work with healthcare systems around the world will expand access to important tools for early cancer detection and personalized trea

    3/23/26 8:50:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $DHI
    $FIVE
    $NFLX
    Leadership Updates

    Live Leadership Updates

    View All

    Abbott HeartMates Community Delivers Holiday Cheer in Hallmark Channel's New Movie "The More the Merrier"

    Movie to feature cameos from youth who have overcome significant heart health challenges and are part of the Abbott HeartMates community as well as professional football player and HeartMates ambassador Damar Hamlin "The More the Merrier" is the first Hallmark movie ever to include cameos from real-life individuals who have overcome cardiovascular challengesCharacter in the movie was inspired by Abbott HeartMates member Zeke Mankins, who has established a friendship with Hamlin through Hamlin's ambassador role for the HeartMates communityMovie premieres on Hallmark Channel on Nov. 28, 2025, during Hallmark's Merry Thanksgiving Weekend during "Countdown to Christmas"ABBOTT PARK, Ill., Nov. 4,

    11/4/25 9:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Five Below Appoints Chief Financial Officer and Chief Merchandising Officer

    PHILADELPHIA, PA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ:FIVE) ("Five Below" or "the Company"), the trend-right, high-quality, extreme-value retailer for the kid and the kid in all of us, today announced the appointments of Daniel Sullivan as Chief Financial Officer (CFO) and Michelle Israel as Chief Merchandising Officer (CMO), effective October 6, 2025. Both executives will report to Winnie Park, Chief Executive Officer. Mr. Sullivan will be responsible for Five Below's financial operations and related strategies, overseeing its Finance, Information Technology and Asset Protection teams. Ms. Israel will be responsible for Merchandising, Planning, Allocation, Product S

    10/1/25 9:25:00 AM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    Synchrony Names Deborah Ellinger to Board of Directors

    Strategic leader and boardroom veteran enhances expertise in health and wellness, and consumer retail STAMFORD, Conn., Sept. 29, 2025 /PRNewswire/ -- Synchrony Financial (NYSE: SYF), a premier consumer financial services company, today announced Deborah Ellinger, a former CEO and experienced board member with extensive experience across multiple industries, including health and wellness and retail, has been appointed to Synchrony's Board of Directors, effective October 1, 2025. "I am delighted to join the Synchrony Board," said Ms. Ellinger. "The Company is committed to drivin

    9/29/25 4:05:00 PM ET
    $SYF
    Finance: Consumer Services
    Finance

    $ABT
    $DHI
    $FIVE
    $NFLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Five Below Inc.

    SC 13G/A - FIVE BELOW, INC (0001177609) (Subject)

    11/14/24 1:28:32 PM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Five Below Inc.

    SC 13G/A - FIVE BELOW, INC (0001177609) (Subject)

    11/14/24 1:22:35 PM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Five Below Inc.

    SC 13G/A - FIVE BELOW, INC (0001177609) (Subject)

    11/12/24 9:55:17 AM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary